Drais Pharmaceuticals
Bridgewater
About Drais Pharmaceuticals
Drais Pharmaceuticals, Inc. is a venture capital supported drug development company with an exciting new business model. Through strong relationships with Astellas Pharma Inc. and our venture capital investors - InterWest Partners, Sutter Hill Ventures, and Astellas Venture Management LLC, we have created multiple virtual companies to enable the development of interesting novel compounds in a variety of therapeutic areas. Our focus is on early stage development through proof of concept. Our business model relies on a small internal team who provide drug development services to those virtual companies via vendors and CROs. Our internal experts are able to move compounds rapidly through key development milestones and decision points, thus de-risking programs early in development.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $33.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Jun 2012)
- Website: draispharma.com
- Phone: 908-895-1200
Industries & Categories
Biopharma, Biotechnology, Health Care, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/drais-pharmaceuticals-2238533 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.